Visualization of lipid components in human coronary plaques using color fluorescence angioscopy

Circulation Journal

Volumn 74, Issue 10, 2010, Pages 2181-2186

  Uchida, Yasumi ^a,b,c   Uchida, Yasuto ^d   Kameda, Noriaki ^c  

^a The Japan Foundation   (Japan)

^b Chiba kensei Hospital   (Japan)

^c TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^d TOHO UNIVERSITY   (Japan)

Author keywords

Color fluorescence angioscopy; Coronary plaque; Homidium bromide; Lipid components; Trypan blue

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ANGIOSCOPY; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOFLUORESCENCE IMAGING; COLOR FLUORESCENCE ANGIOSCOPY; CORONARY PLAQUE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE DISPLAY; LIPID ANALYSIS; LIPID COMPOSITION; LIPID STORAGE; MALE; PROTEIN LOCALIZATION;

ANGIOSCOPY; APOLIPOPROTEINS B; ATHEROSCLEROSIS; COLOR; CORONARY ARTERY DISEASE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MICROSCOPY, FLUORESCENCE; PLAQUE, ATHEROSCLEROTIC;

EID: 77958064850     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0451     Document Type: Article

References (25)

1. Matsuura E, Hughes GR, Khamashta MA. Oxidation of LDL and its clinical implication. Autoimmun Rev 2008; 7: 558-566.
2. Chen JH, Riazy M, Smith EM, Proud CG, Steinbrecher UP, Duronio V. Oxidized LDL-mediated macrophage survival involves elongation of factor-2 kinase. Arterioscler Thromb Vasc Biol 2009; 29: 92-98.
3. Vilani SS, Nambi V. The role of lipoprotein-associated phospholipase A2 as a marker of atherosclerosis. Curr Atheroscler Rep 2007; 9: 97-103.
4. 2+-induced potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis 2007; 190: 100-105.
5. Matsubara M, Hasegawa K. Benipine, a dihydopyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 2005; 178: 57-66.
6. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem 2007; 14: 3209-3220.
7. Messner MG, Albert CJ, McHowat J, Ford DA. Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions. Lipids 2008; 43: 245-249.
8. Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, Lerman LO, et al. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: Association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 2007; 115: 2715-2721.
9. Berliner JA, Leitinger N, Tsimikas S. The role of oxidized phospholipids in atherosclerosis. J Lipid Res 2009; 50(Suppl): S207-S212.
10. Cromwell WC, Barringer TA. Low-density lipoprotein and apolipoprotein B: Clinical use in patients with coronary heart disease. Curr Cardiol Rep 2009; 11: 468-475.
11. Matter CM, Schuler PK, Alessi P, Meier P, Ricci R, Zhang D, et al. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Circ Res 2004; 95: 1225-1233.
12. Jaross W, Neumeister V, Lattke P, Schuh D. Determination of cholesterol in atherosclerotic plaques using near-infrared diffuse reflection spectroscopy. Atherosclerosis 1999; 147: 327-337.
13. Weinmann P, Jouan M, Nguyen QD, Lacroix B, Groiselle C, Bonte JP, et al. Quantitative analysis of cholesterol and cholesteryl esters in human atherosclerotic plaques using near-infrared Raman spectroscopy. Atherosclerosis 1998; 140: 81-88.
14. Uchida Y. Coronary angioscopy: From tissue imaging to molecular imaging. Curr Cardiovasc Imaging Rep 2009; 2: 284-292.
15. Uchida Y, Uchida Y, Kawai S, Kanamaru R, Sugiyama Y, Tomaru T, et al. Detection of vulnerable coronary plaques by color fluorescent angioscopy. J Am Coll Cardiol Imaging 2010; 3: 398-408.
16. Uchida Y, Uchida Y, Kawai S, Kanamaru R, Kameda N. Imaging of lysophosphatidylcholine by color fluorescence angioscopy. Int Heart J 2010; 51: 129-133.
17. Yamada N. Molecular biology of atherosclerosis. Nihonrinsyo 2002; 60(Suppl 10): 87-94.
18. Uchida Y. Coronary angioscopy. Futura Publishing Co, Armonk, NY. 2001; 41-80.
19. Takano M, Mizuno K. Coronary angioscopic evaluation for serial changes of luminal appearance after pharmacological and catheter interventions. Circ J 2010; 74: 240-245.
20. Ueda Y, Ogasawara N, Matsuo K, Hirotani S, Kashiwase K, Hirata A, et al. Acute coronary syndrome: insight from angioscopy. Circ J 2010; 74: 411-417.
21. Uchida Y, Nakamura F, Tomaru T, Morita T, Sasaki T. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J 1995; 130: 195-203.
22. Ralph P, Nakoinz I. Environmental and chemical dissociation of antibody-dependent phagocytosis from lysis mediated by macrophages: Stimulation of lysis by sulfhydryl-blocking and elastaseinhibitory agents and depression by trypan blue and trypsin. Cell Immunol 1980; 50: 94-105.
23. Brooks BO, Reed ND. The effect of trypan blue on the early control of Trypanosoma musculi parasitemia in mice. J Reticuloendothel Soc 1979; 25: 325-328.
24. Kume T, Okura H, Yamada R, Kawamoto T, Watanabe N, Neishi Y, et al. Frequency and special distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: An ex vivo validation and an initial in vivo feasibility study. Circ J 2009; 73: 1086-1091.
25. Kunita E, Fujii T, Urabe Y, Tsujiyama S, Maeda K, Tasaki N, et al. Coronary plaque stabilization followed by color code plaque analysis with 64-slice multidetector row computed tomography. Circ J 2009; 73: 772-775.